Public Company News

Venus Acquisition Corporation Announces Closing of Business Combination; MicroAlgo Inc. to trade on Nasdaq under the Symbol "MLGO".

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Venus Acquisition Corporation (the "Company" or "Venus") (NASDAQ: VENA) today announced that, onDecember 9, 2022, the Company closed the previously announced business combination (the "Business Combination") with VIYI Algorithm Inc. (the "VIYI") pursuant...

2022-12-13 00:25 4085

TD Holdings, Inc. Awarded Top 100 China Industrial Internet Enterprise of 2022

SHENZHEN, China, Dec. 12, 2022 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider in China, today announced that its online to offline e-commerce commodities trading platform, tongdow.com, was awarded Top 100 China Industrial Internet Enterpris...

2022-12-12 22:00 4192

Pop Culture Group's Joint Venture to Receive Growth Investment from Nest Investment Management Co., Ltd.

XIAMEN, China, Dec. 12, 2022 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company's joint venture, Shenzhen Jam Box Technology Co., Ltd ("JBT"), entered into an equity investme...

2022-12-12 22:00 3949

CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatat the 2022 American Society of Hematology (the "ASH") Annual Mee...

2022-12-12 21:50 3048

Yum China Achieves Highest Score in its Industry for the Third Consecutive Year on the Dow Jones Sustainability Index

Green power purchase program launched with two pilot restaurants SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced that the Company was ranked the best in the 88 companies assessed in the Restaurant & Leisur...

2022-12-12 21:41 3839

Tantech Participated in Setting International Standards for Bamboo-based Activated Carbon

LISHUI, China, Dec. 12, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, Zhejiang Tantech Bamboo Charcoal Co., Ltd., had received a certificate from the Bamboo and Rattan Technical Committee of the International Organizatio...

2022-12-12 21:30 3163

PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)

DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company has entered into a clinical collaboration agreement with MSD (Merck & Co...

2022-12-12 21:00 2996

Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Hexvix®, a drug used for bladder c...

2022-12-12 20:59 2311

Scienjoy Holding Corporation Reports Interim Nine months ended September 30, 2022 Unaudited Financial Results

Revenues up 21.2% Year Over Year Income from Operations up 15.3% Year Over Year BEIJING, Dec. 12, 2022 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "We") (NASDAQ: SJ), a leading live entertainment mobile streaming platform inChina, today announced its unaudited fin...

2022-12-12 20:00 3936

China Automotive Systems Launches New Electric Power Steering Systems for BYD

WUHAN, China, Dec. 12, 2022 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that it has introduced a new series of Electric Power Steering ("EPS") systems for the largest Ch...

2022-12-12 19:00 3178

JinkoSolar's High-efficiency N-Type Monocrystalline Silicon Solar Cell Sets Our New Record with Maximum Conversion Efficiency of 26.4%

SHANGRAO, China, Dec. 12, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has achieved a major technical breakthrough for its 182 mm high-efficien...

2022-12-12 18:16 2670

Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the first patient enrolled in phas...

2022-12-12 17:47 2240

Acer Listed on Dow Jones Sustainability Indices (DJSI) 2022; Achieves Its Highest Ranking in Nine Years

Recognized among industry leaders in the THQ Computers & Peripherals and Office Electronics category at No. 2 TAIPEI, Dec. 12, 2022 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced that it has been listed on the Dow Jones Sustainability Indices (DJSI) Emerging Markets Index in 2022 for the ninth...

2022-12-12 14:33 2873

JITC publication of Akeso's Ligufalimab(CD47 monoclonal antibody) mechanism shows promising antitumor efficacy and favorable safety profile

HONG KONG, Dec. 11, 2022 /PRNewswire/ -- Akeso Inc. (9926. HK) ("Akeso") today announced that the Journal for Immunotherapy of Cancer (JITC), a BMJ oncology journal, published the mechanism of action of its Ligufalimab (AK117).The article's name is "Ligufalimab, a novel anti-CD47 antibody with no...

2022-12-12 12:59 2672

HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery

CHENGDU, China, Dec. 11, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. ("Nitrase"), a biopharmaceutical company deploying its NITROME platform to buil...

2022-12-12 10:10 2739

Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate

BCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64th American Society of Hematology Annual Meeting and Exposition SAN DIEGO and SUZHOU and SHANGHAI, China, Dec. 10, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL)...

2022-12-11 07:15 4473

Sentage Holdings Inc. Announces Financial Results for the First Six Months of Fiscal Year 2022

SHANGHAI, Dec. 9, 2022 /PRNewswire/ -- Sentage Holdings Inc. (the "Company", "we", "our") (Nasdaq: SNTG), is a holding company incorporated in theCayman Islands with no material operations of its own. Through its China-based operating entities, the Company offers a comprehensive range of financia...

2022-12-10 05:15 7682

ReneSola Power Announces Results of Annual General Meeting

STAMFORD, Conn., Dec. 9, 2022 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com <>) (NYSE: SOL), a leading fully-integrated solar projectdeveloper, today announced the results of its 2022 annual general meeting of shareholders. Specifically, the Company's ann...

2022-12-10 05:01 7275

iQIYI Launches World's First Virtual Reality Game Show Memoon Player

BEIJING, Dec. 9, 2022 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, released the virtual reality (VR) variety game showMemoon Player with the first episode airing on Dec. 9. An iQIYI original production,Memoon Player invites viewers to join the show par...

2022-12-09 19:04 3973

ChipMOS REPORTS NOVEMBER 2022 REVENUE

HSINCHU, Dec. 9, 2022 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), ...

2022-12-09 19:00 4194
1 ... 526527528529530531532 ... 763

Week's Top Stories